Pier Paolo Berton Giachetti

Pier Paolo Berton Giachetti is currently a Specializzando at IEO Istituto Europeo di Oncologia, focusing on the Development of new drugs for innovative therapies since January 2021. Previously, Pier Paolo undertook a clinical research internship at ICS Maugeri SpA Società Benefit, where involvement included gene silencing of proteins related to cardiovascular disease pathogenesis, particularly catecholaminergic polymorphic ventricular tachycardia. Early in their career, Pier Paolo wrote articles and guides for o2o.it, part of the Banzai Group. Educational qualifications include a Doctor of Medicine degree from Università degli Studi di Milano and Università di Pavia, attained between 2013 and 2019, alongside a classical high school diploma from Liceo classico Leone XIII.